Talk:4-Androstene-3,6,17-trione

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about 4-Androstene-3,6,17-trione.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Untitled

after creatine my fav supplement —The preceding unsigned comment was added by 199.245.32.11 (talk • contribs).

Banned

Isn't this banned in the U.S. just like Androstenedione. Quadzilla99 17:17, 15 January 2007 (UTC)[reply]

,No because it is an aromatase inhibitor and not a prohormone. --Bk0 (Talk) 22:42, 15 January 2007 (UTC)[reply]

Seeing as how there are a lack of scientific studies, is there anyone out there with anecdotal evidence? Especially any powerlifters? Also, is this banned by the international powerlifting federation? Doesn't seem to be on their list.

New research

There's some new research on 6-OXO, check it out: http://www.jissn.com/content/4/1/13 I'm not sure if anyone's actively watching this article, but I thought I'd see if someone responds, otherwise I'll go about and rewrite the article. Jack Daw 14:00, 29 October 2007 (UTC)[reply]

Interesting research. Please feel free to add it into the article text. --Bk0 (Talk) 22:17, 31 October 2007 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just modified one external link on 4-Androstene-3,6,17-trione. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

Added archive https://web.archive.org/web/20120513020202/http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf to http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 07:22, 25 May 2017 (UTC)[reply]